Did not become law. It stopped in the General Assembly on October 20, 2016. The 2016–2017 session has ended.
2016–2017 Session
Assembly Bill 3793
Clarifies that product approval from U.S. Food and Drug Administration is not required for drug manufacturer to file registration statement, and specifies timeframe by which DOH must review registration statements.
Sponsors
Who carried the bill in each chamber, and who signed on. Each name leads to the member's page.
In the General Assembly
Sponsor from May 19
Chief co-sponsor from Oct 7
Herb Conaway Jr., Raj Mukherji, Daniel R. Benson, Angela V. McKnight
Chief co-sponsors from Oct 20
2 co-sponsors
Its course
May 23 to October 20, 2016, on one scale. In the top row each mark is a day something happened; taller marks are busier days.
Each committee stop sits inside its chamber.
Every action3 actions on 3 days
In the General AssemblyMay 23 to Oct 20 · stopped150 days
Health and Senior ServicesMay 23 to Oct 6136 days
Text
Each version as the Legislature printed it.
l9n doesn't hold this bill's text yet.
What happened
In l9n's words, one line for each step. Every action as the Legislature published it is below.
In the General Assembly May 23 – Oct 20
- May 23Introduced in the General Assembly and sent to Health and Senior Services
- Oct 6Health and Senior Services recommended it
- Read a second time
- Oct 20Carried on in S2024
All 3 actions, as published
- May 23INT 1RA REF AHEGeneral Assembly
- Oct 6REP 2RAGeneral Assembly
- Oct 20SUB BYGeneral Assembly